{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:50:13Z","timestamp":1790027413099,"version":"4.0.1"},"reference-count":54,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since November 2018, Blood Advances has published American Society of Hematology (ASH) clinical practice guidelines on venous thromboembolism, immune thrombocytopenia, and sickle cell disease. More ASH guidelines on these and other topics are forthcoming. These guidelines have been developed using consistent processes, methods, terminology, and presentation formats. In this article, we describe how patients, clinicians, policymakers, researchers, and others may use ASH guidelines and the many related derivates by describing how to interpret information and how to apply it to clinical decision-making. Also, by exploring how these documents are developed, we aim to clarify their limitations and possible inappropriate usage.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001755","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T20:12:16Z","timestamp":1589314336000},"page":"2095-2110","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["A user guide to the American Society of Hematology clinical practice guidelines"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-4396","authenticated-orcid":false,"given":"Ariel","family":"Izcovich","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, German Hospital, Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-5697","authenticated-orcid":false,"given":"Adam","family":"Cuker","sequence":"first","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kunkle","sequence":"first","affiliation":[{"name":"American Society of Hematology, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Neumann","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and"},{"name":"Centro Evidencia UC, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Panepinto","sequence":"first","affiliation":[{"name":"Children\u2019s of Wisconsin, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menaka","family":"Pai","sequence":"first","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Seftel","sequence":"first","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Cheung","sequence":"first","affiliation":[{"name":"Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lottenberg","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Byrne","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, Vanderbilt University, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Plovnick","sequence":"first","affiliation":[{"name":"American Society of Hematology, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdra","family":"Terrell","sequence":"first","affiliation":[{"name":"Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Holter-Chakrabarty","sequence":"first","affiliation":[{"name":"Stephenson Cancer Center, Division of Hematology\/Oncology\/Transplantation and Cellular Therapy, Department of Medicine, University of Oklahoma, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Djulbegovic","sequence":"first","affiliation":[{"name":"Department of Supportive Care Medicine and"},{"name":"Department of Hematology, City of Hope, Duarte, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Hicks","sequence":"first","affiliation":[{"name":"Department of Medicine, St. Michael\u2019s Hospital, Toronto, ON, Canada;"},{"name":"Faculty of Medicine, University of Toronto, Toronto, ON, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-1650","authenticated-orcid":false,"given":"Wojtek","family":"Wiercioch","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre, and"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robby","family":"Nieuwlaat","sequence":"first","affiliation":[{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre, and"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-8479","authenticated-orcid":false,"given":"Holger J.","family":"Sch\u00fcnemann","sequence":"first","affiliation":[{"name":"Department of Medicine, McMaster University, Hamilton, ON, Canada;"},{"name":"Michael G. DeGroote Cochrane Canada Centre,"},{"name":"McMaster GRADE Centre, and"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"22","key":"2020051211342582600_B1","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"issue":"22","key":"2020051211342582600_B2","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"22","key":"2020051211342582600_B3","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/bloodadvances.2018024828","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism","volume":"2","author":"Lim","year":"2018","journal-title":"Blood Adv"},{"issue":"22","key":"2020051211342582600_B4","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv"},{"issue":"22","key":"2020051211342582600_B5","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"issue":"22","key":"2020051211342582600_B6","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"issue":"23","key":"2020051211342582600_B7","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","article-title":"American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients","volume":"3","author":"Anderson","year":"2019","journal-title":"Blood Adv"},{"key":"2020051211342582600_B8","doi-asserted-by":"crossref","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","author":"Ortel","DOI":"10.1182\/bloodadvances.2020001830"},{"issue":"23","key":"2020051211342582600_B9","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"key":"2020051211342582600_B10","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","author":"DeBaun","journal-title":"Blood Adv"},{"issue":"2","key":"2020051211342582600_B11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/bloodadvances.2019001143","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support","volume":"4","author":"Chou","year":"2020","journal-title":"Blood Adv"},{"issue":"23","key":"2020051211342582600_B12","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1182\/bloodadvances.2019000916","article-title":"American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease","volume":"3","author":"Liem","year":"2019","journal-title":"Blood Adv"},{"issue":"7","key":"2020051211342582600_B13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"2020051211342582600_B14","article-title":"Clinical Practice Guidelines We Can Trust","author":"Greenfield","year":"2011"},{"issue":"5","key":"2020051211342582600_B15","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1371\/journal.pmed.0040119","article-title":"Transparent development of the WHO rapid advice guidelines","volume":"4","author":"Sch\u00fcnemann","year":"2007","journal-title":"PLoS Med"},{"issue":"5","key":"2020051211342582600_B16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1513\/pats.201208-053ST","article-title":"A guide to guidelines for professional societies and other developers of recommendations: introduction to integrating and coordinating efforts in COPD guideline development. An official ATS\/ERS workshop report","volume":"9","author":"Sch\u00fcnemann","year":"2012","journal-title":"Proc Am Thorac Soc"},{"key":"2020051211342582600_B17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1748-5908-7-62","article-title":"Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development","volume":"7","author":"Shekelle","year":"2012","journal-title":"Implement Sci"},{"issue":"3","key":"2020051211342582600_B18","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Sch\u00fcnemann","year":"2014","journal-title":"CMAJ"},{"key":"2020051211342582600_B19","doi-asserted-by":"crossref","first-page":"l4606","DOI":"10.1136\/bmj.l4606","article-title":"Distinguishing opinion from evidence in guidelines","volume":"366","author":"Sch\u00fcnemann","year":"2019","journal-title":"BMJ"},{"key":"2020051211342582600_B20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12916-016-0563-0","article-title":"Idiopathic pulmonary fibrosis\u2014clinical management guided by the evidence-based GRADE approach: what arguments can be made against transparency in guideline development?","volume":"14","author":"Rochwerg","year":"2016","journal-title":"BMC Med"},{"key":"2020051211342582600_B21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-5908-7-60","article-title":"Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest","volume":"7","author":"Eccles","year":"2012","journal-title":"Implement Sci"},{"key":"2020051211342582600_B22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-4505-4-12","article-title":"Improving the use of research evidence in guideline development: introduction","volume":"4","author":"Oxman","year":"2006","journal-title":"Health Res Policy Syst"},{"issue":"4","key":"2020051211342582600_B23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-3445","article-title":"Methods for development of the European Commission Initiative on Breast Cancer Guidelines: recommendations in the era of guideline transparency","volume":"171","author":"Sch\u00fcnemann","year":"2019","journal-title":"Ann Intern Med"},{"issue":"7","key":"2020051211342582600_B24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med"},{"issue":"10","key":"2020051211342582600_B25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1164\/rccm.200804-494OC","article-title":"The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis","volume":"178","author":"Jaeschke","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2020051211342582600_B26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2020051211342582600_B27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1398-9995.2009.01973.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions","volume":"64","author":"Brozek","year":"2009","journal-title":"Allergy"},{"issue":"7454","key":"2020051211342582600_B28","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"2020051211342582600_B29","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"2020051211342582600_B30","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"issue":"7","key":"2020051211342582600_B31","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Sch\u00fcnemann","year":"2003","journal-title":"CMAJ"},{"key":"2020051211342582600_B32","article-title":"Using systematic reviews in guideline development: the GRADE approach [published online ahead of print 14 July 2018]","author":"Zhang","journal-title":"Res Synth Methods"},{"key":"2020051211342582600_B33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Sch\u00fcnemann","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jclinepi.2019.02.003","article-title":"GRADE guidelines: 22. The GRADE approach for tests and strategies-from test accuracy to patient-important outcomes and recommendations","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B35","article-title":"GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables [published online ahead of print 10 February 2020]","author":"Sch\u00fcnemann","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B36","article-title":"GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy [published online ahead of print 12 February 2020]","author":"Sch\u00fcnemann","journal-title":"J Clin Epidemiol"},{"issue":"7653","key":"2020051211342582600_B37","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. [published correction appears in BMJ. 2008;336(7654)]","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"2020051211342582600_B38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2020051211342582600_B39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation\u2019s direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jclinepi.2016.03.018","article-title":"Interpreting GRADE\u2019s levels of certainty or quality of the evidence: GRADE for statisticians, considering review information size or less emphasis on imprecision?","volume":"75","author":"Sch\u00fcnemann","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"Hultcrantz","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jclinepi.2018.05.011","article-title":"GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences - inconsistency, imprecision, and other domains","volume":"111","author":"Zhang","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jclinepi.2018.01.013","article-title":"GRADE guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-risk of bias and indirectness","volume":"111","author":"Zhang","year":"2019","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2020051211342582600_B44","doi-asserted-by":"crossref","first-page":"e0229004","DOI":"10.1371\/journal.pone.0229004","article-title":"Approval processes in evidence-based clinical practice guidelines sponsored by medical specialty societies","volume":"15","author":"Sonis","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"2020051211342582600_B45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M19-2125","article-title":"Breast cancer screening and diagnosis: a synopsis of the European breast guidelines","volume":"172","author":"Sch\u00fcnemann","year":"2020","journal-title":"Ann Intern Med"},{"key":"2020051211342582600_B46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2016.07.006","article-title":"Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group","volume":"80","author":"Guyatt","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B47","article-title":"Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations and experiences","author":"Wiercioch","journal-title":"Blood Adv"},{"issue":"4","key":"2020051211342582600_B48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"2020051211342582600_B49","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1182\/bloodadvances.2019000462","article-title":"Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines [published correction appears in Blood Adv. 2020;4(7):1219]","volume":"4","author":"Etxeandia-Ikobaltzeta","year":"2020","journal-title":"Blood Adv"},{"key":"2020051211342582600_B50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1748-5908-8-6","article-title":"Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results","volume":"8","author":"Treweek","year":"2013","journal-title":"Implement Sci"},{"key":"2020051211342582600_B51","article-title":"Development and use of health outcome descriptors: a guideline development case study","author":"Baldeh","year":"","journal-title":"Health Qual Life Outcomes"},{"key":"2020051211342582600_B52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"2020051211342582600_B53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/asheducation-2014.1.387","article-title":"Pregnancy and venous thromboembolism: \u2018TIPPS\u2019 for risk stratification","volume":"2014","author":"Rodger","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"10060","key":"2020051211342582600_B54","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomized controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/9\/2095\/1728704\/advancesadv2020001755c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/9\/2095\/1728704\/advancesadv2020001755c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T01:33:17Z","timestamp":1615685597000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/9\/2095\/455055\/A-user-guide-to-the-American-Society-of-Hematology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,5,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001755","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]}}}